0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe
K-Number: K161552 · 2017-02-02
Device Summary
Frequently Asked Questions
What is the 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?
0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is a medical device that received FDA 510(k) clearance on 2017-02-02. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K161552.
When did 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe receive FDA 510(k) clearance?
0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe received FDA 510(k) clearance on 2017-02-02, under 510(k) number K161552.
Who is the listed applicant for 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?
The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe?
The FDA product code for 0.9% Sodium Chloride Injection, USP BD PosiFlush SP Syringe is NGT.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Becton, Dickinson and Company as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: NGT)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.